Invariant natural killer T cells treated with rapamycin or transforming growth factor-β acquire a regulatory function and suppress T effector lymphocytes
Crossref DOI link: https://doi.org/10.1038/cmi.2015.20
Published Online: 2015-04-06
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Guggino, Giuliana
Scottà, Cristiano
Lombardi, Giovanna
Dieli, Francesco
Sireci, Guido
Text and Data Mining valid from 2015-04-06
Version of Record valid from 2015-04-06
Article History
Received: 14 February 2015
Accepted: 14 February 2015
First Online: 6 April 2015